List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 122 studies with search of: "Vorinostat"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated
Has Results 		A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Vorinostat;   Drug: Vorinostat;   Drug: Vorinostat;   Drug: Vorinostat;   Drug: erlotinib
2 Recruiting Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer
Condition: Malignant Solid Tumour
Intervention: Drug: Zolinza (vorinostat), vinorelbine
3 Completed
Has Results 		Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]) in combination with Pemetrexed and Cisplatin
4 Recruiting SAHA + CHOP in Untreated T-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Zolinza (vorinostat);   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone
5 Recruiting Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme;   Anaplastic Glioma
Interventions: Drug: Vorinostat;   Drug: Carboplatin;   Drug: Isotretinoin;   Other: No Surgery;   Procedure: Surgical Resection
6 Not yet recruiting Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Vorinostat;   Drug: Bortezomib
7 Terminated Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
Condition: Non-Small Cell Lung, Prostate, Bladder/Urothelial Cancers.
Interventions: Drug: vorinostat (suberoylanilide hydroxamic acid);   Drug: docetaxel
8 Recruiting Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
Condition: Brain Metastases
Interventions: Drug: Vorinostat;   Radiation: Radiation Therapy
9 Recruiting A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Paclitaxel, Carboplatin and Vorinostat
10 Recruiting Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Vorinostat
11 Recruiting Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Vorinostat, Carboplatin, Etoposide;   Other: Vorinostat, Carboplatin, Etoposide
12 Recruiting Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Vorinostat, Bevacizumab, Carboplatin, Paclitaxel;   Drug: Vorinostat, Bevacizumab, Carboplatin, Paclitaxel
13 Recruiting Combination of Sorafenib and Vorinostat in Poor-Risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Promyelocytic, Acute;   Myelodysplastic Syndromes
Intervention: Drug: Sorafenib-Vorinostat
14 Not yet recruiting Vorinostat Plus Radiation Therapy in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Radiation: Radiation;   Drug: Vorinostat
15 Recruiting HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Condition: Advanced Breast Cancer
Intervention: Drug: Vorinostat
16 Active, not recruiting A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer
Conditions: Advanced Cancer Relapsed;   Advanced Cancer Refractory
Interventions: Drug: vorinostat;   Drug: Comparator: placebo (unspecified)
17 Not yet recruiting Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Conditions: Hematologic Malignancies;   Graft vs Host Disease
Interventions: Procedure: reduced intensity, matched related donor stem cell transplant;   Drug: tacrolimus (standard GVHD prophylaxis);   Drug: mycophenolate (standard GVHD prophylaxis);   Drug: vorinostat
18 Recruiting Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: suberoylanilide hydroxamic acid;   Drug: tamoxifen citrate
19 Recruiting Vorinostat (MK0683, SAHA) + Revlimid + Dexamethasone in Multiple Myeloma
Condition: Relapsed or Refractory Multiple Myeloma
Interventions: Drug: vorinostat;   Drug: Comparator: lenalidomide;   Drug: Comparator: Dexamethasone
20 Active, not recruiting Phase IIa Vorinostat (MK 0683, SAHA) Study in Lower Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Blood Disease;   Bone Marrow Disease
Intervention: Drug: vorinostat

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services